CD274 and neuroblastoma: In addition, Su et al. observed that anlotinib treatment in neuroblastoma mice reprogrammed the immunosuppressive tumour microenvironment (TME) into an immune-stimulatory TME, leading to an extension in the duration of vascular normalisation, and dynamic changes in the expression levels of PD-1 and PD-L1.